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Abstract 
The genetic material of every organism exists within the context of regulatory networks 
that govern gene expression, collectively called the epigenome. Epigenetics has taken 
center stage in the study of diseases such as cancer and diabetes, but its integration 
into the field of environmental health is still emerging. As the Environmental Mutagenesis 
and Genomics Society (EMGS) celebrates its 50th Anniversary this year, we have come 
together to review and summarize the seminal advances in the field of environmental 
epigenomics. Specifically, we focus on the role epigenetics may play in multi and trans-
generational transmission of environmentally induced health effects. We also summarize 
state of the art techniques for evaluating the epigenome, environmental epigenetic 
analysis, and the emerging field of epigenome editing. Finally, we evaluate transposon 
epigenetics as they relate to environmental exposures and explore the role of non-
coding RNA as biomarkers of environmental exposures. While the field has advanced 
over the past several decades, including being recognized by EMGS with its own 
Special Interest Group, recently renamed Epigenomics, we are excited about the 
opportunities for environmental epigenetic science in the next 50 years.   
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Introduction: The Role of the Environmental Epigenomics in Health and Disease 
 
Epigenetics is the collective term for the study of mitotically heritable and potentially 
reversible changes in gene expression unrelated to changes to the DNA sequence itself. 
Epigenetic marks include chromatin modifications (e.g. histone protein acetylation, 
methylation, and ubiquitination), non-coding long and small RNA (e.g. lncRNA, miRNA, 
piRNA), and alterations to DNA itself (e.g. DNA methylation and hydroxymethylation). 
Epigenetics has taken center stage in the study of chronic diseases such as cancer, 
obesity, diabetes, and neurodegeneration; however, its integration into the field of 
environmental health sciences and toxicology is only a few decades old. For example, 
the developmental origins of health and disease (DOHaD) work of David Barker and 
 1 
This article is protected by copyright. All rights reserved.
This is the author manuscript accepted for publication and has undergone full peer review but
has not been through the copyediting, typesetting, pagination and proofreading process, which
may lead to differences between this version and the Version of Record. Please cite this article
as doi: 10.1002/em.22311
colleagues showed that a child’s environment during gestation and soon after birth 
influences his or her risk of developing disease later in life (Bateson et al. 2004). The 
molecular basis, however, for this implausible mode of inheritance of disease risk was 
unknown until 2003, when Drs. Randy Jirtle and Robert Waterland published a seminal 
paper in Molecular and Cellular Biology (Waterland and Jirtle 2003). The stunning 
physical differences in the genetically identical mice seen in Figure 1 are the result of 
the epigenetic status of a metastable epiallele (shown is the murine Avy viable yellow 
Agouti locus). In this model, Jirtle and colleagues demonstrated that maternal dietary 
supplementation with methyl donors including betaine, methionine, and folic acid, alters 
the offspring coat color distribution of the offspring. More importantly, they identified DNA 
methylation of a transposable element upstream of the Agouti gene as the molecular 
basis for this shift (Waterland and Jirtle 2003). This observation marked the advent of a 
new field of scientific investigation: environmental epigenomics. 
 
Despite a growing interest in the integration of epigenetics into toxicology and 
translational sciences, recent advances of the field have not yet fully incorporated 
epigenetics into research, risk assessment, or epigenome editing applications. To honor 
the 50th Anniversary of the Environmental Mutagenesis and Genomics Society (EMGS), 
we provide a primer on the principles and practices critical to understanding the role of 
the epigenome in regulating gene expression and the resulting response of cells, 
tissues, and individuals to environmental exposures. We first discuss how the work of 
Jirtle and Waterland has been extended to evaluate multi- and trans-generational effects 
of perinatal exposures. We next focus on the complexity of tissue and even cell type 
epigenomic specificity by highlighting the National Institute of Environmental Health 
Sciences' (NIEHS) multi-phased Toxicant Exposures and Responses by Genomic and 
Epigenomic Regulators of Transcription (TaRGET) Program (Wang et al. 2018). As 
epigenetics encompasses genes, non-coding elements, regulatory regions, and 
transposons, we next describe the use of transposons as epigenetic biomarkers. We 
finish with a discussion of the emerging need to expand beyond DNA methylation in 
environmental epigenetics research to also include non-coding RNAs as biomarkers of 
exposures and mechanisms of disease risk. Finally, new advances in epigenome 
editing, including our recent work on the potential of piRNA DNA methylation editing, will 
be explored for environmental health research (Perera et al. 2019). 
 
Multi- and Trans-Generational Transmission of Environmentally-Induced Health 
Effects  
 
Gestation as a Sensitive Period for Environmentally Induced Epigenetic Changes 
Epigenetic regulation can be modified by the environment and these changes contribute 
to growth, development, and disease risk (Faulk and Dolinoy 2011). The epigenome, 
and DNA methylation in particular, is especially sensitive to environmental perturbation 
in the early stages of gestation when epigenetic patterns that can be inherited across 
subsequent cell divisions are being set up. Hundreds of studies in human cohorts and 
animal models have shown associations between the gestational environment and 
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epigenetic change in the offspring. These studies provide evidence for epigenetic 
change as one mechanism underlying the DOHaD hypothesis (Barouki et al. 2018). For 
example, differential DNA methylation is associated with gestational exposures to 
toxicants (e.g., lead, arsenic, bisphenol A, cigarette smoke (Cardenas et al. 2015; 
Goodrich et al. 2015; Anderson et al. 2016; Joubert et al. 2016; Wu et al. 2017; Alavian-
Ghavanini et al. 2018; Junge et al. 2018), maternal stress (Mulligan et al. 2012; Non et 
al. 2014), and maternal diet (Waterland and Jirtle 2003; Dolinoy et al. 2006; Burdge et al. 
2007; Amarasekera et al. 2014; Gonzalez-Nahm et al. 2017). Understanding the 
influence of gestational environmental exposures on the offspring epigenome is thus an 
important part of risk assessment for toxicants. In addition to epigenetic effects by 
gestational environment on the F1 offspring, there is evidence for F2 grandoffspring 
epigenetic changes (Rehan et al. 2012; Mitchell et al. 2016) since the fetal germ cells 
are directly exposed during this time (Figure 2), and even F3-F4 transgenerational 
effects on subsequent generations that were never exposed (Anway et al. 2005; 
Manikkam et al. 2014). This section will highlight several examples of changes to 
offspring, grandoffspring, or great-grandoffspring DNA methylation following gestational 
exposures and will briefly describe common approaches for DNA methylation analysis 
that can be applied to studies in this area.  
 
Examples of Multigenerational Epigenetic Effects 
As mentioned above, perhaps the most striking rodent examples of the impact of the 
early gestational environment on offspring phenotype through epigenetic change stem 
from the Avy mouse model (Figure 1). Avy is a metastable epiallele, an allele that is 
variably expressed among individuals due to epigenetic modifications established early 
in development (Rakyan et al. 2002). As such, metastable epialleles are particularly 
vulnerable to early environmental influences, including diet, toxicants, and radiation. In 
the Avy mouse model, coat color throughout life and obesity status and tumor 
susceptibility in adulthood correlate with whether the Avy allele is turned on or off through 
DNA methylation and histone modifications in early development. The epigenetic status 
of this locus has been shown to be associated with early gestational exposures to 
genistein, a methyl-donor enriched diet, bisphenol A, lead, and other dietary agents or 
environmental toxicants, all of which continue to impact the offspring’s health later in the 
life course (Waterland and Jirtle 2003; Dolinoy et al. 2006; Dolinoy et al. 2007; Kaminen-
Ahola et al. 2010; Bernal et al. 2013; Faulk et al. 2013b).  
 
Epidemiological studies have employed genome-wide screening approaches across 
multiple tissues to identify potential metastable epialleles in humans and to determine 
their response to the environment (Waterland et al. 2010a; Dominguez-Salas et al. 2014; 
Silver et al. 2015). For example, a natural experiment in rural Gambia compared 
individuals with periconceptual exposure to the dry versus rainy season, which largely 
impacts diet, and found differential methylation of the VTRNA2-1 epiallele, which 
persisted into later childhood (Silver et al. 2015). Genomic imprinting is an epigenetic 
process that allows a subset of autosomal genes to be expressed exclusively from one 
allele, in a parent-of-origin-specific manner. Thus, imprinted genes are another set of 
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candidates to consider in environmental epigenetics due to their unique characteristics, 
including parent-of-origin dependent regulation and key functions in early life growth 
(Lawson et al. 2013). Importantly, DNA methylation of many imprinted genes is 
responsive to the gestational environment. For example, DNA methylation at well-
characterized differentially methylated regions, including the imprinting control regions of 
IGF2 and H19 are associated with prenatal exposures to smoking, phthalates, folate, 
malnutrition, and more in epidemiological studies (Heijmans et al. 2008; Murphy et al. 
2012; Tobi et al. 2012; Hoyo et al. 2014; LaRocca et al. 2014). There is also evidence 
that this epigenetic alteration is persistent – even into late adulthood (Heijmans et al. 
2008) – and contributes to adverse health outcomes including low birth weight, 
adolescent adiposity, and adiposity in post-menopausal women (Huang et al. 2012b; 
Murphy et al. 2012; Song et al. 2018).    
 
Rodent and human studies have provided evidence for the theory that primordial germ 
cells are uniquely susceptible to epigenetic change by grandmaternal exposures, and 
these exposures can thus impact health of not only the F1 but also the F2 generation 
(Sales et al. 2017). In epidemiological studies, grandmother smoking on the maternal 
side was associated with autistic traits (Golding et al. 2017), asthma with allergies 
(Accordini et al. 2018), and obesity (Ding et al. 2017) among F2 grandchildren. In a rat 
model, following F0 exposure to nicotine during gestation, the F1 and F2 generations 
both displayed alterations in lung function that were consistent with effects on 
myofibroblast differentiation. Importantly, changes to both global DNA methylation and 
histone acetylation were observed in lung and gonad tissues of the F1, suggesting an 
epigenetic underpinning for F2 effects (Rehan et al. 2012).  
 
Examples of Transgenerational Epigenetic Effects 
Evidence for environmentally-induced transgenerational effects via germline 
epimutations that transmit beyond the exposed generations is recently coming to light 
(Skinner 2015). Transgenerational reproductive toxicity including decreased epididymal 
sperm count and reduced sperm motility were first reported in four generations of male 
rats following F0 pregnancy exposure to the fungicide vinclozolin and the pesticide 
methoxyclor (Anway et al. 2005). These transgenerational effects were associated with 
inherited epigenetic marks, including DNA methylation in the male germline (Anway et 
al. 2005; Manikkam et al. 2014). Exposure-specific sperm DNA methylation profiles 
transmitted through the F3 generation have been reported in rats for a pesticide mixture, 
a plastics mixture, jet fuel, and dioxin (Manikkam et al. 2012). Overall, these studies 
draw attention to the need to assess whether other common exposures lead to 
transgenerational epimutations and health effects. The well-characterized model 
organisms, zebrafish and C. elegans, may serve as valuable screening species for 
transgenerational effects and their epigenetic underpinnings of a wider array of 
exposures given the fast generational turnover in these species (Greer et al. 2011; 
Carvan et al. 2017; Cavalieri and Spinelli 2017; Camacho et al. 2018).  
 
Methods for DNA Methylation Analysis 
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Candidate Gene or Locus-specific Analysis 
Identifying DNA methylation changes associated with early life exposures has the 
potential to serve as biomarkers of exposure and/or mechanistic links to increased 
disease risk across generations and will improve toxicological risk assessment. Common 
approaches for DNA methylation analysis in human or animal models include quantifying 
DNA methylation at specific genes, transposable elements (TE), or across all or most 
genes (epigenome-wide analyses). Many popular methods for gene-specific analysis 
rely upon sodium bisulfite treatment of the DNA first, which converts unmethylated 
cytosine residues to uracil but leaves methylated cytosines unchanged (Grunau et al. 
2001). These methods include cloning followed by sequencing (Zhang et al. 2009), 
methylation-specific quantitative PCR (Eads et al. 2000), pyrosequencing (Busato et al. 
2018), and more recently, targeted bisulfite sequencing which takes advantage of next 
generation sequencing technology (Bernstein et al. 2015; Wendt et al. 2018). In addition 
to their utility for specific genes, pyrosequencing is widely used to measure both human 
and mouse TE methylation (e.g., LINE1, Alu). The EpiTYPER assay is another popular 
method for gene-specific analysis which involves enzyme digestion after amplification of 
bisulfite-converted DNA, creating fragments of different mass based on methylation 
status which are then analyzed via mass spectrometry (Suchiman et al. 2015).  
 
Epigenome-wide Analysis 
The most common tools used in epigenome-wide association studies in human 
populations have been the Illumina Infinium series of probe-based arrays which quantify 
DNA methylation at single CpG site resolution, needing as little as 250 ng of bisulfite 
converted DNA as input. The first two versions of this platform, the Infinium 
HumanMethylation27 and HumanMethylation450 BeadChips provided coverage at 
>27,000 and >480,000 CpG sites. In December 2015, the latest version of the Infinium 
array, the MethylationEPIC BeadChip, was released which quantifies DNA methylation 
at >850,000 CpG sites across all known genes and in intergenic and key regulatory 
regions (e.g., gene promoters, enhancers (Moran et al. 2016)). Apart from the Infinium 
arrays, next generation sequencing- based methods are gaining popularity as these 
methods can be used for any species with a mapped genome and costs are decreasing 
(Bock et al. 2010; Zhao et al. 2014; Ziller et al. 2015). In additional to bisulfite-conversion 
based sequencing methods, antibody based methods can be used to semi-quantitatively 
measure methylation at transposons or genome-wide. Referred to as methylated DNA-
immunoprecipitation (Me-DIP), these methods involve using anti-5mC antibodies to 
immunoprecipitate methylated DNA (Zhao et al. 2014; Staunstrup et al. 2016). Antibody-
based approaches can also be utilized to evaluate DNA hydroxymethylation, which is 
also emerging as an environmentally-responsive modification (Kochmanski et al. 2018a; 
Kochmanski et al. 2018c). 
 
The NIEHS TaRGET II Consortium and Environmental Epigenomics  
 
Current Challenges in Environmental Epigenomics Studies 
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Although we have made substantial strides in our understanding of how environmental 
exposures impact the epigenome and human health, several factors continue to pose 
significant challenges and limitations. These include tissue specificity of environmental 
exposures, tissue and cellular heterogeneity, sexually dimorphic effects, and the effects 
of age and stress on exposure-related epigenetic changes and health outcomes. First, 
human environmental epigenomics studies are limited by tissue accessibility, as access 
to most disease-relevant tissues targeted by environmental exposures is not possible. 
Thus, human studies typically rely on surrogate tissues, including blood, hair, and skin, 
to gain insight into the effects of environmental exposures on inaccessible target tissues. 
However, the extent to which epigenetic changes in surrogate tissues reflect those in 
target tissues is currently unclear. Second, it is increasingly clear that there is significant 
heterogeneity within tissues, and even within individual cell types, with respect to gene 
expression and patterns of epigenetic marks (Cheow et al. 2016; Cusanovich et al. 
2018; Ben-Moshe and Itzkovitz 2019). Thus, assessment of tissue-specific effects of 
environmental exposures may be masked by such heterogeneity. Moreover, 
environmental exposures may induce changes in the cellular composition of tissues 
(Trevino and Katz 2018; Hung et al. 2019), complicating the interpretation of epigenetic 
studies. These challenges may be addressed through emerging methods in single cell 
analyses (Cheow et al. 2016). Third, significant evidence demonstrates that the effects 
of toxicant exposures are highly sex-specific (Faulk et al. 2013b; Bansal et al. 2017; 
Kundakovic 2017; Neier et al. 2019; Winterbottom et al. 2019). Given that there are also 
significant sex disparities in the prevalence and outcomes of many diseases associated 
with environmental exposures (Graham 2015; DeSantis et al. 2017), an understanding of 
how environment differentially affects disease risk in a sex-specific fashion is critical. 
Finally, although cross sectional studies have clearly demonstrated environment-induced 
epigenetic changes (Montrose et al. 2018; Curtis et al. 2019; Winterbottom et al. 2019), 
whether these changes persist across time in both surrogate and target tissues is not 
well understood. Notably, environmental exposures can alter the trajectory of age-
related epigenetic changes (Fraga et al. 2005; Faulk et al. 2014; Krauskopf et al. 2018). 
However, it is currently unclear whether these interactions between environment and 
aging are uniform across tissues. It will therefore be important to consider age-
environment interactions in the design of human toxicoepigenetics studies.  
 
The NIEHS TaRGET Consortium 
In order to address these important issues, and to aid in the design and analysis of 
human environmental epigenetics studies, the NIEHS developed the TaRGET program. 
The first phase of this program, TaRGET I, was formed in 2012 to investigate how 
environmental exposures affect the cellular machinery critical for establishment of 
normal epigenetic patterning (Prins et al. 2014; Wang et al. 2016). During the second 
phase of the project, a multi-institutional consortium, TaRGET II, was established to 
investigate the conservation of environment-induced epigenetic signatures across 
multiple target and surrogate tissues and cells (Wang et al. 2018). Using a common 
mouse model and a well-defined treatment paradigm, consortium members are 
investigating the effects of several perinatal environmental exposures, including lead 
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(Pb), diethylhexyl phthalate (DEHP), bisphenol A (BPA), arsenic (As), dioxin (TCDD), 
and particulate matter (PM2.5) on the epigenome and transcriptome in multiple target 
and surrogate tissues (Wang et al. 2018) (Figure 3). These analyses are conducted at 
three separate time points during the lifespan of the offspring, including the early 
postnatal period, early adulthood, and late adulthood, in order to investigate whether 
perinatal toxicant-induced epigenetic programming persists as the animals age. 
Collectively, work from this project is anticipated to provide valuable insight into the 
tissue-, cell-, and sex-specific effects of environmental exposures on epigenetic 
programming across the lifespan. These findings will aid in the design and interpretation 
of human population-based epigenomics studies, which will be the focus of the TaRGET 
III and TaRGET IV phases of the project. 
 
Pb Exposure and Tissue-specific DNA Methylation 
As part of the TaRGET consortium, we are investigating the effects of perinatal Pb 
exposure on epigenetic and transcriptional programming of offspring mice, using the 
consortium mouse model of environmental exposures. We recently investigated the 
effects of perinatal Pb exposure on DNA methylation in mouse liver and blood, to 
determine whether common signatures exist between the two tissues, whether these 
signatures are sex-specific, and whether they persist into adulthood (Abstract presented 
at Society of Toxicology Annual Meeting, Baltimore, MD, 2019). For these studies, dams 
were exposed to Pb acetate (32 ppm) as outlined previously (Faulk et al. 2013b) via 
drinking water for two weeks prior to mating, and Pb exposure continued throughout 
pregnancy and lactation. Offspring were weaned at three weeks of age, and Pb 
exposure ceased at this time point. Between 3 weeks and 5 months of age, offspring 
were given standard chow and Pb-free drinking water. Six male and six female mice 
were euthanized at 5 months of age, and blood and liver were collected according to 
TaRGET II consortium-approved protocols. Thus, this two-stage study design allows for 
the assessment of transient as well as persistent epigenetic modifications, as transient 
changes may readily occur immediately following exposures but may not persist over 
time when the exposure is removed.  
 
To determine the effects of Pb exposure on DNA methylation, within TaRGET II, we 
utilized enhanced reduced-representation bisulfite sequencing (ERRBS), which allows 
the detection of base pair resolution DNA methylation at CpG-rich loci (Garrett-
Bakelman et al. 2015). Notably, although Pb exposure ceased at 3 weeks of age, our 
studies revealed thousands of differentially methylated regions (DMRs) that persisted 
into adulthood. DMRs were highly sex-specific, with few regions overlapping between 
blood and liver. In females, 3 DMRs overlapped between blood and liver, although the 
changes in methylation with Pb exposure were in the opposite direction in the two 
tissues. In males, there were 4 DMRs that overlapped between blood and liver, with two 
loci, mapping to Grifin and Plekhg3, which exhibited concordant changes in methylation 
with Pb exposure. These findings suggest that perinatal Pb exposure results in stable 
changes in DNA methylation in the blood and liver of offspring mice, with few sites 
directly overlapping between the two tissues or across sexes. Ongoing studies are 
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focused on determining whether other epigenetic signatures in the blood may reflect Pb-
induced changes in liver and other target tissues, including brain.  
 
It is notable that Pb-induced changes in DNA methylation persisted into adulthood, 
although the functional consequences of these changes are currently unclear. Notably, 
recent work suggests that early-life environment can induce epigenetic changes that are 
“silent”, but render the target genes hyper-responsive to hormonal cues later in life 
(Greathouse et al. 2012; Wang et al. 2018). Indeed, Wang et al. demonstrated that early 
life exposure to BPA induced reprogramming of the activating H3K4me3 histone mark at 
prostate cancer-associated genes that persisted into adulthood (Wang et al. 2016). 
Intriguingly, several of the BPA-reprogrammed genes exhibited no change in basal 
expression; however, they were hyper-responsive to subsequent hormonal stimulation 
(Wang et al. 2016). These findings suggest that changes in epigenetic marks may 
provide a more reliable signature of early-life environmental exposures than changes in 
gene expression. The data also suggest that the functional consequences of toxicant-
induced epigenetic programming may only manifest upon subsequent environmental 
insult. Thus, in future studies it will be important to investigate how subsequent 
environmental exposures, nutritional perturbations, and stressors later in life interact with 
early epigenetic programming to initiate or exacerbate disease. Future research is 
required to understand the persistence of environmentally induced alterations on 
epigenome in order to determine transient versus persistent epigenetic changes 
associated with environmental exposures. 
 
Transposons as Epigenetic Targets  
 
Transposons 
Transposable elements (TEs) are small regions of DNA that have evolved the ability to 
copy themselves throughout the genome. Referred to as repetitive elements, mobile 
DNA, or transposons they are found in all animals. Varying in size from 250 nt to over 
7000 nt they can encode protein machinery that enables their jumping ability (Huang et 
al. 2012a). These mobile elements have several origins, including endogenous 
retroviruses that have incorporated themselves into the genome, or gene fusions that 
have gained the ability to copy themselves. Subsequently, they have spread throughout 
the genome. They are delineated in classes, such as short or long interspersed 
elements (SINEs and LINEs) which dominate the genome, and subcategorized into 
families and subfamilies based on sequence similarity and presumed copying origin 
(Bao et al. 2015).  
 
Mammalian genomes consist of approximately 50% of sequence derived from 
transposons, as opposed to just ~1% of sequence coding for genes (Platt et al. 2018). 
Despite the consistency of this fraction across mammals, the composition of the 
transposon sequence varies widely between species. Generally, there is a balance 
between TE proliferation and host genome suppression, often through epigenetic 
mechanisms (Canapa et al. 2015). Most mammals have at least one actively 
 8 
This article is protected by copyright. All rights reserved.
transposing family of TEs. They are inherited from parent to offspring, rarely transferring 
horizontally between species. While “selfish,” due to their ability to promote their own 
transmission at the expense of other genes, these TEs can often be adapted to serve 
the host as a source of raw variation and mutation (Dupressoir et al. 2012). Some 
elements are enriched in CpG sites or other useful features for evolution, so their 
proliferation throughout the genome can be adaptive.  
 
Humans are illustrative of transposon dynamics in the genome. The most abundant TE 
by number in the human genome is the Alu element, a short ~300 nt element that does 
not encode its own transposition machinery and is present in about 1.2 million copies in 
primate genomes (Deininger 2011). It relies upon the reverse transcriptase protein for 
mobilization, encoded by the most abundant transposon by percentage nucleotide in the 
human genome, the LINE1 element. The LINE1 is >6000 nt and is present in >100,000 
copies in the human genome making up 18% of the genome, but most are 5’ truncated, 
with around 100 LINE1s suspected to be capable of activity and just 6 “hot” LINEs 
provide over 80% of the observed transposition in cell culture (McLaughlin 2018). Both 
elements can contribute to disease by several mechanisms including transpositional 
mutation breaking a gene, by causing homology mediated deletions, or most relevant 
here, by disruption of chromatin or nearby gene expression (Beck et al. 2011; Rebollo et 
al. 2011). Alus are primate specific, while LINE1s are found across all vertebrates. Both 
are used as epigenetic biomarkers of exposure and disease status. 
 
Epigenetic Relevance of TE Insertions 
In mammals and other organisms, the fifth carbon of cytosines in a CpG context can be 
methylated. Deamination of methylated cytosine results in a thymine base. Transitions 
from C to T account for up to 42% of all mutations in the human genome, far more than 
any other transition or transversion, most occurring at a methylated CpG sites (Gojobori 
et al. 1982). The rapid turnover of CpG sites to either TpG or CpA has important 
implications in evolution. Whereas humans have a 1% sequence divergence from 
chimpanzees on average, at CpG sites the mutation rate rises to 15% (Chimpanzee and 
Analysis 2005). Over evolutionary time, mammalian genomes have lost CpG sites from 
an expected frequency of 6.25% to an observed frequency of less than 1% of 
dinucleotides. Since DNA methylation is crucial for gene regulation, CpG sites at high 
density CpG islands (CGIs) near gene promoters must be replenished somehow 
(McLain and Faulk 2018). Transposons are typically silenced by DNA methylation at 
CpG sites to prevent their movement from disrupting the genome. However, non-random 
TE insertions appear to provide new CpG sites via their ability to copy paste sequence 
throughout the genome. In humans, the Alu element is both enriched in CpG sites and 
found at higher density near CGIs and therefore replenishes CpG sites, providing 
flexibility in methylation status near genes (Gu et al. 2016).  
 
Transposons as Epialleles 
In mice, the intracisternal A particle (IAP) element is an endogenous retrovirally derived 
transposon and is responsible for ~10% of de novo mutations found in inbred strains. 
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The high mobilization activity of IAP has resulted in high polymorphism as well, with 60% 
being private to specific strains (Zhang et al. 2008). The IAP is capped on both ends by 
long terminal repeats (LTRs) that are relatively CpG dense and have bidirectional 
promoter activity. Typically, these CpG sites are silenced through DNA methylation, 
however several IAPs have been shown to be variably methylated between mice, with 
consistent methylation across tissues, hallmarks of metastable epialleles. The Avy mouse 
differential coat colors (Figure 1) are driven by promoter activity at insufficiently silenced 
CpG sites within the LTR of an IAP insertion. Generally, most IAPs are completely reset 
between generations and only rarely escape reprogramming (Kazachenka et al. 2018). 
Several studies in humans have also identified potential epialleles hosting differential 
methylation in various classes of TEs (Waterland et al. 2010b; Faulk et al. 2016). 
 
Benefits of Transposons as Biomarkers 
TEs have several characteristics that make them useful as biomarkers of exposure and 
disease status. Many classes are found widely throughout the genome and there are 
multiple copies per genome. They are not under selective constraint. They are usually 
heavily methylated, so any change in methylation status is suggestive of strong 
environmental impact. In practice, their sequence similarity allows thousands of loci to 
be amplified in a single PCR reaction with a single set of primers. Measuring the DNA 
methylation of these amplicons gives an average methylation value for all TEs of a 
specific class, usually Alu in humans or LINE1 in humans and mice. Given their relatively 
uniform spread across the genome, their methylation serves as a proxy for global 
methylation across the genome.  
 
Epidemiological Biomarkers in Human Exposure 
When studying populations for environmental exposures that are associated with 
disease, two main transposon assays have been used. The most widely used measure 
are taken with LINE1 and Alu elements, originally developed by Yang et al. to measure 
methylation in a PCR pool using primers matching consensus sequences of these two 
families (Yang et al. 2006). The LINE1 pyrosequencing assay was initially used to 
measure genomic instability in cancer but has been adapted for epidemiological studies 
(Estecio et al. 2007). The Alu and LINE1 assays, while both considered global, have 
different methylation levels by tissue, and have distinct responses to environmental 
exposures (Price et al. 2012). For example, both Alu and LINE 1 correlate to preterm 
birth (Burris et al. 2012), whereas LINE1 but not Alu was affected by exposure to 
prenatal air pollution (Breton et al. 2016). While too numerous to list here, these 
epigenetic biomarkers have shown response to mercury (Narvaez et al. 2017), traffic 
particles (Baccarelli et al. 2009), industrial environments (Alvarado-Cruz et al. 2017), 
aging and ischemic heart disease (Baccarelli et al. 2010), carbon nanotubes (Ghosh et 
al. 2017), and polycyclic aromatic hydrocarbons (Lee et al. 2017a). The Alu assay has 
been used to study response to persistent organic pollutants in Koreans (Kim et al. 
2010; Lee et al. 2017b), and Inuit (Rusiecki et al. 2008). Nearly all studies of toxicant 
exposures report hypomethylation of LINE1. Fewer studies report Alu methylation 
responses. 
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Use as Biomarkers in Mice 
There is considerable interest in the use of TEs as biomarkers environmental exposures 
that alter DNA methylation. Studies have examined methylation of a subset (Faulk et al. 
2013a) or the entire genomic complement of TE methylation in mice (Kazachenka et al. 
2018). Locus-specific measurements of TE DNA methylation allow detection of 
differential methylation for individual TE insertions and can be considered causal for 
disruption of nearby gene expression (Rebollo et al. 2011). Potentially, incompletely 
silenced TEs could transcribe in unintended ways; indeed studies have shown hundreds 
of protein isoforms that express a fusion of a TE and a native gene (Ekram et al. 2012). 
Locally, several IAP elements show methylation response to perinatal lead exposure 
(Montrose et al. 2017) and phthalates (Neier et al. 2019). Globally, IAP elements have 
been used as genome-wide epigenetic biomarkers, showing hypomethylation in 
transcription factor binding sites (Shimosuga et al. 2017). Prenatal inflammation can 
impact murine LINE1 methylation in the brain (Basil et al. 2014). Radiation induces 
hypomethylation at LINE1 and the SINE B1 in mouse hematopoietic progenitors 
(Miousse et al. 2014). In contrast, at least one study showed low dose radiation does not 
affect methylation of several TEs including IAP, B1, and LINE1 longitudinally (Newman 
et al. 2014). Similarly, a study by Tommasi et al. found no methylation changes in these 
same element families upon exposure to secondhand smoke (Tommasi et al. 2012). 
However, trichloroethylene exposure does alter IAP methylation in immune cells, which 
is of great interest given its widespread use as an obstetric analgesic (Gilbert et al. 
2012). Regarding longitudinal studies, LINE1 and IAP elements have been used to 
measure epigenetic drift over time (Faulk et al. 2014; Kochmanski et al. 2017), during 
aging (Barbot et al. 2002) and by dietary exposure (Kochmanski et al. 2018b). 
 
Caveats of TEs as Epigenetic Biomarkers 
The nature of repetitive elements produces several caveats that should be considered 
when analyzing TE methylation data. Most importantly, the lack of conserved CpG sites 
between various copies of a family of TEs can mask the true methylation level. Assays 
are built to compare CpG site methylation by using a consensus sequence that is the 
average of thousands of TEs of a particular family. Often individual TE copies will have 
mutations at the location of CpG sites when compared to the consensus. In sequencing 
methods, for example, a read may come from a family member that has a TpG mutation 
SNP at CpG site annotated in the consensus. This position would be erroneously read 
as an unmethylated CpG site. Since methylation is often calculated as percentage C to 
non-C, over thousands of elements or reads, methylation level can appear anomalously 
low at specific CpG sites. The true methylation level at CpG sites that exist in TE copies 
is usually very high in reality. For Alu elements, Yang et al. found only 36% of potential 
CpG sites maintained in aggregate PCR products (Yang et al. 2004). Of these, 85% 
were methylated. Another major difficulty arises from the similar, but non-identical, 
nature of TE family members. Performing multiple alignments can be difficult, leading to 
undercounting of true TE copies.  
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Despite these caveats, methylation assessment between studies is comparable, and 
deviance from control group methylation level usually indicates an environmental cause. 
Therefore, the continued use of TEs as epigenetic biomarkers has a bright future, as 
long as the underlying biology of TEs is understood by those who measure them. 
 
Non-coding RNA and Epigenome Editing Tools as Potential Interventions  
 
An Introduction to non-coding RNA 
Although non-coding RNA (ncRNA) was previously considered as products of “junk 
DNA”, recent scientific advancements have concluded that ncRNA are functional RNA 
molecules that arise from DNA, which do not translate to specific proteins (Boland 2017). 
These ncRNAs are critical for biological functions as they are involved in complex 
biochemical and epigenetic regulatory mechanisms (Angrish et al. 2018). The genome 
encodes for long ncRNAs (lncRNAs), which are non-protein coding transcripts >200 
nucleotides and small ncRNAs (sncRNAs), which are of much shorter lengths in 
comparison. lncRNAs are functionally distinct from sncRNA and are involved in 
biological processes such as genomic imprinting, X-chromosome inactivation, and 
development (Kung et al. 2013; Dhanoa et al. 2018).  
 
On the other hand, sncRNAs include several regulatory RNA species such as microRNA 
(miRNA) that are involved in mRNA transcription, short interfering RNAs (siRNAs) that 
are involved in transcriptional repression, PIWI-interacting RNAs (piRNAs) that are 
involved in transposon silencing, and small nucleolar RNAs (snoRNAs) that interact with 
other RNA and proteins for gene regulation. Based on current knowledge, miRNAs and 
siRNAs are roughly ~20 nucleotides in length, and are associated with Ago proteins to 
silence genes via transcriptional and translational silencing mechanisms within the RNA 
interference (RNAi) pathway, while germline piRNAs are typically 24-32 nucleotides in 
length, in comparison (Lin 2007). In contrast, PIWI proteins are important for piRNA 
biogenesis and forming the piRNA-induced silencing complex (piRISC) to induce DNA 
methylation for silencing of transposable elements in the germline (Tan et al. 2015). 
Therefore, the PIWI-piRNA interactions are functionally distinct from that of other 
sncRNAs (Han et al. 2017a), including several structural attributions that are distinct 
from other sncRNAs: preference for a 5’ uridine signature, presence of an adenosine 
signature at the 10th position, a 2’-O-methylation modification at the 3’ ends, and 
clustering within a 20-90 kb length region (Lin 2007; Zuo et al. 2016).  
 
Circular RNAs (circRNAs) are another class of ncRNA species, which are a product of 
back-splicing of linear pre-mRNA that join together a donor site with an upstream 
acceptor site (Salzman 2016). In some cases, circRNAs serve as molecular sponges 
that regulate transcription by removing miRNAs (Carrara et al. 2018). They are 
associated with cancer, Alzheimer’s disease, diabetes, cellular stress, aging, and 
genomic imprinting (Han et al. 2017b; Qu et al. 2017; Perera et al. 2018). Although 
miRNAs are by far the most studied class of sncRNA species in many fields including 
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cancer, environmental toxicology, and risk assessment, future research in other sncRNA 
species may lead to similar breakthroughs based on their distinct cellular functions. 
 
ncRNA Biomarkers Relevant for Human Health and Disease 
The fields of genomics, toxicoepigenetics, and environmental epigenetics have greatly 
benefitted from the technological advancements and increasing power of sequencing, 
transcriptomics, and bioinformatics over the past few years. It provides much needed 
information to better understand the genetics and environmental factors that influence 
human health and disease. Thus, the discovery of ncRNA biomarkers related to a wide 
array of human disease stages and environmental exposures contribute towards 
identifying novel ncRNAs for precision medicine (Karlsson and Baccarelli 2016; Roy et 
al. 2018). A few, recent studies in the field of environmental toxicology have provided 
evidence for lncRNA biomarkers associated with response to environmental stressors 
such as EDCs, metals, cigarette smoke extracts, and genotoxic agents (Bhan et al. 
2014; Bi et al. 2015; Zhou et al. 2015; Karlsson and Baccarelli 2016), where genes are 
regulated by complex cellular and molecular mechanisms which are yet unknown.  
 
SncRNA and circRNA biomarkers are often times preferred over lncRNAs since they are 
small, versatile, resistant to degradation, and widely available in biospecimens (Bahn et 
al. 2015). The most extensively studied ncRNA biomarkers are miRNAs, which are 
associated with EDC exposures (De Felice et al. 2015), metals (Sanders et al. 2015), 
pollution (Krauskopf et al. 2018), and several human diseases (Siddeek et al. 2014; De 
Felice et al. 2015; Sanders et al. 2015; Ehrlich et al. 2016; LaRocca et al. 2016; Romano 
et al. 2017; Krauskopf et al. 2018). The piRNA biomarkers may also be considered for 
future studies due to their expression in human blood, stability (due to the 2’-O-
methylation modification at its 3’ end), and tissue-specificity (Yang et al. 2015; Zuo et al. 
2016). Although piRNAs are extensively studied and highly expressed from the germline, 
recent studies have provided evidence for piRNA expression in the soma (Lin 2007; Zuo 
et al. 2016; Perera et al. 2019). So far, piRNAs have shown associations with chemical 
exposures such as dichlorodiphenyltrichloroethane (DDT) and vinclozolin (Nilsson et al. 
2018; Sai et al. 2018; Skinner et al. 2018) and human health and disease (i.e. cancer) 
(Han et al. 2017a; Chalbatani et al. 2019).  
 
CircRNAs are worthy biomarkers since they are stable, resistant to exonucleases, 
present in liquid biopsies, and highly abundant with specificity towards tissues and stage 
of development (Carrara et al. 2018; Zhang et al. 2018). Thus, circRNAs are becoming 
increasingly popular candidates for diagnosis and clinical interventions in recent cancer 
research, and may serve as a potential ncRNA biomarkers of interest for future research 
(Zhang et al. 2018). Generating reliable ncRNA databases with precise detection 
methods for tissue-, sex-, and developmental stage-specific ncRNA species (i.e. miRNA, 
piRNA, and circRNA) is absolutely necessary to improve ncRNA biomarker identification. 
For instance, the publicly available databases for piRNA mostly consist of germline 
tissues with high incidences of non-specific sequences for somatic tissues (Tosar et al. 
2018; Perera et al. 2019), thus serving as a limitation for biomarker discovery. The less 
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studied ncRNA species such as lncRNA, piRNA and circRNA species are potential 
epigenetic biosensors that may serve as predictors for disease risk and later-life health 
outcomes that could be developed to improve personalized medicine in the future. 
 
Epigenome Editing Techniques  
Epigenome editing/engineering is a technology that manipulates the epigenome without 
disrupting the actual DNA sequence to regulate desired gene expression, which makes it 
a safer therapy in comparison to genome editing. Current technologies that act on the 
epigenome can be categorized as global epigenetic modifiers and target-specific 
epigenetic modifiers, both of which act on epigenetic readers such as Methyl-CpG-
binding proteins (MBPs), histone methylation binding proteins, histone acetylation 
binding proteins; writers such as DNA methyltransferases (DNMTs), histone 
methyltransferases (HMTs), histone acetyltransferases (HATs); and erasers such as 
DNA demethylases, histone demethylases, histone deacetylases (HDACs) (Gillette and 
Hill 2015).  
 
Global epigenetic modifiers include pharmaceutical agents, such as azacytidine, that are 
widely used to inhibit DNMTs, resulting in global hypomethylation in dividing cells (Yang 
et al. 2010; Micevic et al. 2017). HDAC inhibitors such as vorinostat (suberoylanilide 
hydroxamic acid), impact chromatin by maintaining an “open chromatin” configuration, 
facilitating transcriptional activity (Gryder et al. 2012). Advantages of these agents lie in 
their well-characterized use as human therapeutics and for basic research in cell lines 
and animals. Disadvantages of the pharmaceutical approach include their pleiotropic 
effects caused by indiscriminate epigenomic activity and propensity to affect biochemical 
pathways separate from the epigenome. Despite the desperate need for technologies to 
precisely modulate the epigenome, it is unlikely that either small-molecule 
pharmaceuticals or the disruption of chromatin enzymes can be rapidly adapted for 
locus-specific targeting.  
 
Emergence of Targeted Epigenome Editors 
Artificial DNA binding domains (DBDs) fused with catalytic domains of epigenetic 
modifiers have been developed as useful tools to recognize specific DNA sequences 
that introduce or remove epigenetic marks (i.e. DNA methylation, histone modifications) 
at a given locus via Zinc-finger proteins (ZFP), transcriptional activator-like effector 
nucleases (TALENs), and clustered regulatory interspersed palindromic repeats 
(CRISPR) systems (Figure 4) (Waryah et al. 2018). A few critical parameters for 
epigenome editing are specificity and efficiency of the editor, along with stability of the 
edited state. With its initial discovery in 1985 (Miller et al. 1985), the first practical 
method used the DBDs of ZFPs to recruit DNA methylation using DNMTs. In this 
method, iterative phage display selects for a ZFP that recognizes a 9-12 bp motif and 
the resulting encoding sequence is ligated to the sequence for the methyltransferase 
domain (Figure 4A) (Xu and Bestor 1997). So far, ZFPs have been engineered in 
combination with other DNMTs (Li et al. 2007; Siddique et al. 2013), DNA demethylases 
such as Ten-Eleven translocation (TET) enzymes (Zhao and Chen 2013; Chen et al. 
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2014), and histone modifiers (Groner et al. 2010; Falahi et al. 2013). Major drawbacks 
for this system include high cost for protein domain construction, low specificity due to 
off-target effects, complexity (every zinc-finger domain must be custom evolved to target 
a specific sequence), and motif size limitation (Nemudryi et al. 2014; Waryah et al. 
2018). Since their discovery in 2009 (Boch et al. 2009; Moscou and Bogdanove 2009), 
TALENs are the second method used as potential epigenome editors (Figure 4B) 
(Konermann et al. 2013), where Ten-eleven translocation methylcytosine dioxygenase 
1(TET1)/DNMT3a was used to modify DNA methylation (Maeder et al. 2013) and lysine-
specific demethylase 1 (LSD1) was used to modify the histones (Mendenhall et al. 
2013). The DBDs of the TALEN system contains 7-34 tandem repeats, with each repeat 
binding to the major groove of DNA. Even though TALENs have higher specificity 
compared to ZFN, this technology poses significant limitations in assembly and delivery 
due to its large number of tandem repeats.  
 
The CRISPR and CRISPR-associated (Cas) system is the most recent and impactful 
genome editing technique (Gasiunas et al. 2012; Jinek et al. 2012), which has recently 
become desirable for epigenome editing. This system utilizes guide RNAs (gRNAs) that 
recognize ~20 nucleotide sequences to direct deactivated Cas9 (dCas9) attached to a 
desired epigenome modifying enzyme to its complementary DNA sequence for desired 
effects (Figure 4C) (Waryah et al. 2018). The CRISPR/Cas system has been used for 
targeted demethylation and methylation of genes using dCas9-TET1 and dCas9-
DNMT3a, respectively (Liu et al. 2016; Kantor et al. 2018; Xie et al. 2018). The use of 
dCas9 attached to HATs (p300), HMTs (PRDM3), HDACs, and chromatin-modifying 
complexes (LSD1, KRAB) indicate the wide-applicability of the CRISPR/Cas9 system 
(Gilbert et al. 2013; Hilton et al. 2015; Cano-Rodriguez et al. 2016; Waryah et al. 2018). 
However, high incidence of off-target effects and time taken for screening is one of the 
main drawbacks of this system (Falahi et al. 2015). Nonetheless, use of ZFP, TALENs, 
and CRISPR/Cas9 represent a significant advance in the locus-specific manipulation 
toolkit and are considered standards by which to compare any new methods (Rots and 
Jeltsch 2018). Precisely targeting epigenetic marks at specific regions on the genome at 
a developmental-stage and tissue-specific manner still remains a challenge since the 
molecular mechanisms underlying epigenetic regulation in normal and disease states 
are still not well-understood. 
 
Epigenetic changes that occur due to environmental exposures are also not well-
understood for most exposures. To inform risk assessment of hazardous exposures and 
intervention efforts to reverse toxic effects and disease risk, systematic evaluation and 
rigorous analysis of the epigenome by common exposures is needed. This investigation 
should involve all aspects of epigenetic regulation including DNA methylation at gene 
promoters, histone modifications, RNA-mediated gene silencing mechanisms, genomic 
imprinting, and X-inactivation that are induced by sncRNAs (miRNA, piRNA, circRNA, 
and siRNA). Since recent advancements in miRNA- and siRNA-based ncRNA 
therapeutic approaches have provided much promise (Aagaard and Rossi 2007; Burnett 
et al. 2011; Aliabadi et al. 2016), using a similar ncRNA-based technology to modify the 
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epigenome as a potential intervention is indeed an avenue for future studies. For 
instance, the piRNA class of ncRNA represents a fascinating adaptive mechanism and 
“ready-made” tool for innovation in locus-specific repression through DNA methylation 
(Figure 4D) (Mani and Juliano 2013; Fu et al. 2014). Therefore, it is important to conduct 
research using in vitro cell cultures, tissue samples and vivo animal models to evaluate 
the persistence of epigenetic changes with ncRNA delivery, dosage, and specificity. 
 
Conclusions and Future Directions 
As we have discussed, a comprehensive understanding of the tissue- and even cell-
specific epigenetic effects of toxicant exposures, their interactions with other stressors 
later in life, and their persistence across the lifespan, is an important and lofty goal for 
the next 50 years of the EMGS. We are a Society founded with deep interest and 
expertise in environmental impacts on mutagenesis, and thus focusing on transposons 
that make up so much of the genome is crucial to understanding the mechanistic link 
between the environment and heritable changes in gene expression. Transposons serve 
as both biomarkers and drivers of epigenetic changes and underlie the most well-known 
epigenetic phenotypes in animals. Future human studies of environmental exposures 
should place special emphasis on including transposon epigenetic analysis as both an 
endpoint and explanatory mechanism. The discovery of disease-associated biomarkers 
have rapidly moved recent scientific research from basic to translational sciences, which 
now includes miRNA-based therapies that target-specific interventions (Yu et al. 2018). 
Meanwhile, the current knowledge of less popular ncRNA biomarkers (lncRNA, piRNA, 
circRNA) association in cell-, tissue-, sex-, and developmental stage-specific 
environmental exposures or disease states still needs to be carefully examined.  
 
As relatively few chemicals have been evaluated for effects on the epigenome, the 
toxicopigenetic effects of a broader array of environmental exposures, especially 
exposures during critical periods of development, should be prioritized for 
comprehensive assessment. The identification of epigenetically-labile genes, such as 
additional metastable epialleles or genes that under environmental deflection with age 
could be prioritized for initial screening. Furthermore, environmentally-associated 
epigenetic changes need to be related to long-term health in order to delineate whether 
changes are on the causal pathway to toxicity and disease or simply biomarkers of past 
exposure without phenotypic implications. Similarly, there is the need to acquire 
knowledge of persistence, duration of persistence, whether altered epigenome status 
can be revertible to prior pre-exposed status, and temporary versus long term health or 
other manifestations of persistent versus revertible effects. Special attention should be 
paid to the evaluation of multi- and transgenerational effects of toxicant exposures. 
Collectively, this information needs to be incorporated into risk assessment and policy. 
With respect to epigenetic effects robustly associated with environmental exposures and 
health outcomes, epigenome-editing interventions could be developed to mitigate health 
risk.   
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Figure 1. One-year-old female genetically identical viable yellow agouti mice (Avy). 
Maternal dietary supplementation with methyl donors such as folic acid, choline, and 
betaine (Waterland and Jirtle 2003) or the phytoestrogen, genistein (Dolinoy et al. 2006), 
shifts the coat color of the offspring from yellow to brown, and reduces the incidence of 
obesity, diabetes, and cancer. Furthermore, these maternal dietary supplements can 
guard the epigenome from the hypomethylating effects of bisphenol A (BPA), a common 
endocrine disrupting chemical used in the production of polycarbonate plastic and epoxy 
resins (Dolinoy et al. 2007). 
 
Figure 2. Direct and Indirect Effects of Exposures Across Multiple Generations. 
Among mammals, maternal exposures during pregnancy may directly influence the 
mother (F0) and child (F1). Future grandchildren (F2) may be impacted as the primordial 
germ cells are also directly exposed. Effects are considered transgenerational when they 
are observed in generations that were not directly exposed (i.e. F3, F4, and beyond in 
this human example).  
 
Figure 3. Conceptual diagram for environmental epigenomics studies. 
Environmental epigenomics studies utilize surrogate tissues as proxies for epigenetic 
changes in target tissues and determine whether these changes correlate with disease. 
Several types of epigenetic changes may represent biomarkers of environmental 
exposures and adverse health outcomes.  
 
Figure 4. Targeted epigenome editors. Epigenetic marks represent DNA methylation 
changes and histone modifications. The open popsicles indicate unmethylated DNA, 
while closed popsicles represent methylated DNA, while the unmodified histone (green 
open dot), is changed to modified histone (red dot) via epigenetic editing. A) ZFP-based 
epigenome editing. B) TALEN-based epigenome editing. C) CRISPR/dCas9 based 
epigenome editing. (sgRNA: single guide RNA; dCas9: deactivated Cas9; NGG/NCC: 
PAM sequence). The effector protein signifies a DNA/histone modifying protein that is 
responsible for the desired epigenetic change. D) potential ncRNA-based epigenetic 
modification. Based on current research that indicates piRNA presence and activity in 
somatic tissues (Perera et al. 2019), other ncRNA species may be used as potential 
candidates for epigenome editing. For instance, mature piRNA that contain a 2’-O-
methylation modification at its 3’ end and its associated PIWIL proteins may be used to 
specifically methylate DNA. 
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